Peptidyl arginine deiminase-4 (PAD4) is indispensable for generation of neutrophil extracellular traps (NETs), which can provide antimicrobial effects during host innate immune response; however, the role of PAD4 against gastrointestinal infection is largely unknown. Herein, we challenged PAD4-deficient (Pad4 −/− ) mice and wild-type (WT) littermates with Citrobacter rodentium (CR), and investigated bacteria clearance and gut pathology. Luminal colonization of CR in Pad4 −/− mice peaked between 11-14 days postinfection, whereas WT mice suppressed the infection by 14 days. We demonstrated that Pad4 −/− mice were unable to form NETs, whereas WT mice showed increased NETs formation in the colon during infection. Pad4 −/− mice showed aggravated CR-associated inflammation as indicated by elevated systemic and colonic pro-inflammatory markers. Histological analysis revealed that transmissible colonic hyperplasia, goblet cell depletion, and apoptotic cell death were more pronounced in the colon of CR-infected Pad4 −/− mice. Treating WT mice with deoxyribonuclease I, which can disrupt NETs generation, recapitulated the exacerbated CR infection and gut pathology associated with the loss of PAD4. Administration of the PAD4 inhibitor, Cl-amidine also aggravated CR infection, but to a lesser extent. Taken together, our findings highlight the importance of PAD4 in the mucosal clearance of CR and in resolving gut-associated inflammation.
INTRODUCTION
Neutrophil extracellular traps (NETs) are released by neutrophils as a host defense mechanism to trap and eliminate diverse pathogens. 1 The formation of NETs are facilitated by a programmed cell death known as 'NETosis', 2 which is dependent on the reactive oxygen intermediates generated by neutrophil prooxidant enzymes, myeloperoxidase (MPO) and NADPH oxidase (NOX2). 3, 4 NETosis is initiated by peptidyl arginine deiminase-4 (PAD4, aka Padi4), an enzyme that catalyzes the removal of the positively-charged −NH 2 group on arginine residues of histone 3 (H3), thus forming citrullinated H3 (H3Cit). This allows chromatin to decondense and thus released as web-like structures decorated by an array of antimicrobial proteins; 5 however, genetic loss of PAD4 abrogates the formation of these NETs. 6 Accordingly, PAD4deficient (Pad4 −/− ) mice have been employed as the in vivo model to demonstrate the role of NETs in various pathological conditions such as wound healing, 7 deep vein thrombosis, 8 bacterial infection and sepsis, 6, 9 and myocardial 10 and liver injury. 11 Despite the increasing scientific endeavors to target PAD4 in treating various diseases, the role of PAD4 in gastrointestinal (GI) infections is severely under-explored.
Citrobacter rodentium (CR) is a Gram-negative murine enteropathogen, which causes attaching and effacing (A/E) lesions in the distal part of the gut. 12 CR primarily colonize the cecal and colonic epithelia, resulting in diarrhea, goblet cell loss and immune cell infiltration such as macrophages and neutrophils, which promote intestinal inflammation. 12 Although CR causes high mortality in sucklings, the course of infection is self-limiting 13 and precipitates transmissible colonic hyperplasia in adult mice. 14, 15 Accordingly, this infection model has been widely used to study the pathogenesis of two clinically important human GI pathogens, i.e., enteropathogenic E. coli (EPEC) and enterohaemorrhagic E. coli (EHEC). 13 Moreover, this model has been utilized to better understand the pathogenesis of various intestinal disorders, i.e., infectious colitis, inflammatory bowel diseases and tumorigenesis. 16 Several studies demonstrate that neutrophils are essential for protection against CR infection, 17, 18 where depletion of neutrophils increased dissemination of bacteria and mortality in mice. 17 However, the role of the neutrophilic enzyme, PAD4 against CR infection remains to be investigated. Herein, we studied the significance of PAD4 in limiting CR infection by employing Pad4 −/− mice. Our results demonstrated that mice lacking PAD4 are unable to form NETs whereas WT mice displayed increased NETs formation in the colon in response to CR infection. Such impairment in Pad4 −/− mice was associated with a delayed clearance of CR even after 28 days post-infection (p.i), whereas WT mice managed to clear the infection. In addition, Pad4 −/− mice also developed a severe intestinal pathology evidenced by increases in colonic hyperplasia and apoptotic cell death that could be due, in part, to their prolonged infection when compared with WT mice. Pharmacological interventions, via administration of deoxyribonuclease I (DNase I) to degrade NETs or CI-amidine to inhibit PAD4 activity, aggravated CR infection in WT mice and recapitulated the intestinal pathology associated with the loss of PAD4. Taken together, our findings underscore the critical role of PAD4 and NETs in ensuring timely clearance of CR and conferring protection from the GI pathology associated with the infection.
RESULTS

PAD4 deficiency impaired NETs formation and clearance of C. rodentium infection
To examine the role of PAD4 against gastrointestinal infection, Pad4 −/− mice and their WT littermates were challenged with CR (1 × 10 9 CFU) intragastrically and monitored for 28 days. Both groups developed loose stools that were indicative of diarrhea (data not shown), but no apparent loss in body weight was observed ( Fig. 1a ). Nonetheless, Pad4 −/− mice displayed more fecal shedding of CR after day 4 onward up to day 16 p.i. and gradually resolved from day 20-28 p.i. (Fig. 1b ). To address whether the increased fecal shedding of CR was due to their greater capacity to colonize the GI tract, we euthanized the mice and measured CR burden in the gut and other organs. Indeed, CR burden was substantially higher in the cecal content, spleen and mesenteric lymph nodes (MLNs) of Pad4 −/− mice than WT mice at day 10 p.i. (Supplemental Fig. 1A -C). When compared to WT, Pad4 −/− mice displayed a pronounced splenomegaly, loss of cecum weight and colomegaly at day 10 p.i. (Supplemental Fig. 1D -F) and day 28 p.i. (Figs. 1c, d). Such outcomes indicate that the loss of PAD4 not only worsened CR infection in the gut, but also increased their dissemination to extra-intestinal organs.
PAD4 deficiency also impeded proper clearance of CR and allowed the pathogen to persist in the gut, spleen and MLNs of Pad4 −/− mice through day 28 p.i.. At this time, WT mice had substantially recovered from the infection with minimal to no detectable levels of CR in fecal shedding and any of the tissues analyzed (Figs. 1e-h). Taken together, these results highlight the mucoprotective role of PAD4, which is necessary for restricting CR colonization in the GI tract and facilitating its clearance during the course of infection.
To visualize colonic NETs formed during CR infection, we immunostained colon sections from control and CR-infected mice for H3Cit (a defining marker for NETs), Ly6G (neutrophil marker) and DNA (DAPI, a nucleus binding dye). Our results showed that WT mice displayed minimal H3Cit positivity at baseline ( Fig. 1i ), but were capable of upregulating colonic H3Cit following CR infection (Fig. 1j ). The pattern of H3Cit staining in CR-infected WT mice resembled web-like structures and was co-localized with Ly6G staining, thus suggesting that they are likely to be a part of NETs. However, such structures were absent in both uninfected and CR-infected Pad4 −/− mice (Figs. 1k-m). Interestingly, we observed few instances of H3Cit positivity in Pad4 −/− mice; however, their lack of strand-like features indicate that they were unlikely to be NETs. Rather, we postulate these staining could be an artifact or a result of H3 citrullinated by other PAD isoforms that are not involved in NETs formation.
Pad4 −/− mice exhibited persistent exacerbated inflammation during C. rodentium infection Considering that gut inflammation is a typical sequela of CR infection, we next asked whether such inflammation could be exacerbated in Pad4 −/− mice that failed to clear CR in a timely manner. To address this possibility, we first measured the levels of fecal Lcn2, a sensitive biomarker for gut inflammation, 19 at different time points of p.i.. As anticipated, fecal Lipocalin 2 (Lcn2) was significantly elevated in Pad4 −/− mice in a trend similar to the levels of CR fecal shedding, which peaks at 10 days p.i. (Fig. 2a ). Likewise, systemic markers of inflammation [serum Lcn2, serum amyloid A (SAA)] and neutrophil signature markers [neutrophil elastase (NE), MPO] were more elevated in CR-infected Pad4 −/− mice than WT mice (Figs. 2b-e). The expression of colonic inflammatory markers, i.e., tumor necrosis factor (TNF-α), keratinocyte-derived chemokine (KC), interleukin (IL)-17, IL-1β, IL-6, interferon-γ (IFN-γ) and inducible nitric oxide synthase (iNOS), were similarly upregulated in Pad4 −/− mice at day 10 p.i. (Supplemental Fig. 2A -G).
The cytokines, IL-22 and IL-17A, are produced by T cells that have been shown to mediate early mucosal host defense against bacterial infection. 20, 21 Although the colonic levels of these cytokines were elevated in both CR-infected WT and Pad4 −/− mice at day 10 p.i., their upregulation was more pronounced in the latter (Figs. 2f, g). Analysis on colonic lamina propria immune cells showed that CR infection significantly increased Th17 (CD3 + CD4 + RORγt + ) cells in WT and Pad4 −/− mice ( Fig. 2h ), albeit less Th17 cells were observed in Pad4 −/− mice when compared to WT mice; however, we did not observe any significant difference in Treg cells (CD4 + CD25 + FoxP3 + ) in both groups (Fig. 2i ). Interestingly, colonic IL-22 and IL-17A levels were subsequently dampened in both CR-infected WT and Pad4 −/− mice at day 28 p.i (Figs. 2j, k). Considering that mucosal IgA is also a key factor in facilitating CR clearance, 22, 23 we next asked whether Pad4 −/− mice display any impediment in their IgA response. In contrast, fecal IgA was substantially elevated in Pad4 −/− mice after day 16 p.i. and persisted to day 28 p.i., when compared to the mildly elevated fecal IgA levels in WT mice ( Fig. 2l ). Such heightened immune responses in CR-infected Pad4 −/− mice may be regarded as part of a compensatory mechanism, albeit inadequate to offset the loss of antimicrobial immunity due to PAD4 deficiency.
C. rodentium infection led to significant colonic hyperplasia in Pad4 −/− mice Histological analysis further revealed that, compared to WT mice, the colons of infected Pad4 −/− mice had substantially increased epithelial ulceration, crypt elongation and hyperplasia, thickening of the mucosa, and depletion of goblet cells at day 28 p.i. (Figs. 3ad). These features are typical hallmarks of CR-induced goblet cell loss 25 and transmissible colonic hyperplasia due to rapid epithelial proliferation, regeneration and repair mechanisms. 13 A similar trend in the above histological parameters were also observed in the colon of CR-infected Pad4 −/− mice analyzed at day 10 p.i (Supplemental Fig. 3A -C). In addition, we observed a significant increase in apoptotic cell death, visualized via TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) staining, in the colonic crypts of Pad4 −/− mice compared with WT mice at day 28 p.i.. Intriguingly, Pad4 −/− mice also displayed a higher basal level of apoptosis in colonic crypts, whereas very few apoptotic cells were observed in the crypts of WT mice (Figs. 3e-g). Collectively, these outcomes suggest that PAD4 deficiency may also impact cell survival in the colon, though further studies are needed to confirm which cell-types were affected.
The colonic pathology induced by CR infection is often associated with the loss of epithelial barrier integrity, thus increasing systemic dissemination of other gut bacteria. 24 To confirm this possibility, we determined the serum immunoreactivity to microbial products in CR-infected mice as a surrogate measure of bacterial translocation. As anticipated, we observed increased levels of IgG generated against E. coli proteins ( Fig. 3h ), in addition to bacterial LPS and flagellin (Supplemental Fig. 3D , E). Such increased permeability to bacteria and their products, in part, substantiate the susceptibility of Pad4 −/− mice to increased CR dissemination during infection.
C. rodentium colonized the gastrointestinal tract more rapidly in Pad4 −/− mice To visualize the kinetics of CR colonization over the course of infection, we challenged WT and Pad4 −/− mice with a bioluminescent strain of CR (ICC180). Mice were fed with alfalfa-free, compositionally-defined purified diet for the duration of this study to minimize the background florescence from the chlorophyll and other pigments present in grain-based chow. The low levels of CR bioluminescence in WT mice was observed to expand from day 1 to 7 p.i. and subsequently receded from day 9 to 14 p.i. In comparison, Pad4 −/− mice displayed a notably more diffuse pattern of CR bioluminescence that intensified from day 3 p.i. onward and persisted to day 14 p.i (Figs. 4a, b ). In line with our earlier observations, the inflammation was more severe in Pad4 −/− than WT mice as evident by the gross colon, splenomegaly, colomegaly and enlarged MLNs (Supplemental Fig. 4A -E). However, there was no loss in body weight between the groups (data not shown). Analysis of CR burden in the spleen, MLNs, cecal content and fecal shedding were consistent with our overall observation that loss of PAD4 increased the susceptibility to CR colonization and dissemination (Supplemental Fig. 4F -I). Histological analysis showed the aggravated colonic histopathology, goblet cell depletion and submucosal edema in CR-infected Pad4 −/− mice (Supplemental Fig. 4J ).
Disruption of NETs aggravated the susceptibility to C. rodentium infection One of the well-characterized role of PAD4 is to initiate the formation of NETs, a web-like structure comprised of neutrophil DNA. 6, 26 Accordingly, the susceptibility of Pad4 −/− mice to CR infection could be potentially due to their inability to generate NETs for trapping, killing and preventing the dissemination of this pathogen. If that is the case, we envisioned that administration of exogenous DNase I to degrade NETs in CR-infected WT mice could recapitulate the aggravated infection and inflammation seen in Pad4 −/− mice. We did not observe any body weight difference between CR-infected WT mice with and without DNase I treatment ( Fig. 5a ). Yet, DNase I-treated mice displayed progressively increasing CR burden in fecal shedding from day 4 p.i. onwards (Figs. 5b, c). DNase I treatment also increased CR burden in the ceca by day 11 p.i. (Fig. 5d ). There is an increasing trend in CR dissemination to the spleen, albeit not reaching significance ( Fig. 5e ). In line with the exacerbated infection, DNase I-treated mice also developed more severe inflammation as evident by their significantly elevated fecal Lcn2, serum Lcn2 and SAA (Figs. 5f-h). Histological analysis affirmed the worsened colonic histopathology, marked by goblet cell depletion and submucosal edema in the DNase I-treated mice (Figs. 5i, j).
Next, we asked whether pharmacological inhibition of PAD4 in mice could also increase their susceptibility to CR infection. Cl-amidine is a water-soluble, cell-permeable pan-PAD inhibitor that inactivates the enzymatic activity of PAD4 by irreversibly modifying its active site cysteine residue. 27 Treating CR-infected WT mice with Cl-amidine did not result in body weight loss, but elevated CR burden in the fecal shedding and fecal Lcn2 levels with an increasing trend in serum Lcn2 (Figs. 6a-d). However, CR burden in the spleen and MLNs was comparable between vehicle and Cl-amidine treated mice (data not shown). Mice given Clamidine nonetheless partially recapitulated the colon histopathology seen in Pad4 −/− mice (Figs. 6e, f), albeit to a lesser extent in severity. Collectively, the findings of this study implicates the importance of PAD4 and NETs formation against CR infection, whereas their loss of function either via genetic deficiency or pharmacologic intervention could worsen the disease.
DISCUSSION
C. rodentium (CR) is one attaching-effacing enteropathogen that transiently infects the murine gut and elicits colonic hyperplasia that are reminiscent of EPEC and EHEC infections in humans. Accordingly, CR has been widely-employed as a model of gut mucosal infection to elucidate the various host-pathogen crosstalk 28 that could be targeted to promote recovery following infection. Among the innate immune cells, neutrophils are the first responder cell-type that institute a first-line of defense against diverse pathogens. 29 Several lines of evidence suggest that neutrophils are indispensable during CR infection 17, 30 whereby their depletion increases systemic dissemination of CR and mortality. 17 Timely recruitment of neutrophils to the site of CR infection has been shown to be dependent on the chemokines released following the activation of pathogen recognition receptors 31, 32 and MyD88 signaling. 17, 33 Incidentally, the loss of chemokine receptor, CXCR2, has been shown to disrupt mucosal influx of neutrophils, which in turn aggravated the colitisassociated diarrhea caused by CR. 34 Notwithstanding the wellappreciated role of neutrophils against CR, it is still unclear whether PAD4 and/or NETs are indispensable for facilitating CR clearance and mucosal restitution.
A prevailing paradigm proposes that the formation of NETs requires the activity of PAD4, which removes the positivelycharged -NH 2 group on the arginine residues of histone 3 (H3) to allow the chromatin to unwind and be released as NETs. 26 Although the DNA itself has antimicrobial properties, 35 its primary role in NETs is to entrap the encroaching bacteria while leaving them vulnerable to the bactericidal activity of various neutrophil proteins decorating the NETs. 36, 37 Mice deficient in PAD4, however, have been shown to be incapable of forming NETs and thus are more susceptible to bacterial infection. 6 However, the endeavor to visualize NETs in inflamed tissues remains challenging as the contemporary methodologies used to assess NETs in vitro are not feasible for in vivo study. To address this limitation, we probed for H3Cit as a surrogate, if not a definitive marker, for NETs released in the intestine. Our results illustrated the presence of colonic H3Cit decorating the mesh-like structures, which we presumed to be NETs following CR infection. Such contention is supported by our observation that (i) H3Cit co-localized with Ly6G + neutrophils and that (ii) such features were absent in Pad4 −/− mice.
In this study, we found evidence that Pad4 −/− mice were not able to subdue CR infection in the gut, resulting in increased pathogen burden and dissemination. This notion was substantiated via IVIS imaging of the bioluminescent CR, which exhibited a diffuse pattern that expanded more rapidly in Pad4 −/− mice when compared to WT mice. Pad4 −/− mice also displayed a more severe colonic hyperplasia and apoptosis that were likely due, in part, to their prolonged infection and the inability to adequately clear the pathogen. Intriguingly, the fecal shedding of CR in Pad4 −/− mice gradually decreased after the peak of infection around day 12-16 p.i. This decline in CR burden at the later time points could be potentially due to the participation of other immune responses, such as upregulation of colonic IL-22 and IL-17A observed at day 10 p.i. and the elevation of fecal IgA levels that occured after 16 day p.i. Such notion is in line with previous reports demonstrating the importance of IL-22 and IL-17A as antimicrobial cytokines, which confer protection against CR infection. 20, 21, 38 Moreover, the adaptive immune response (T and B cells) also participates in clearing CR infection, 23, 39 albeit delayed. Such responses, though beneficial to promote CR clearance at later time points, were insufficient to compensate for the loss of PAD4 and/or NETs, especially in regards to alleviating the extent of colonic injury and inflammation incurred by CR infection.
Though the pathology observed in Pad4 −/− mice can be largely attributed to NETs deficiency, such a presumption needs to be carefully investigated considering that PAD4 may have other functions on transcriptional regulation via epigenetic mechanisms. 40 Studies to date have employed DNase I, which can effectively degrade NETs in vivo, to directly implicate the role of NETs in various experimental disease models. 7, 36 It has been shown that targeting NETs with DNase I could accelerate wound healing 7 and treat disorders such as kidney injury, 41 systemic lupus erythematosus (SLE), 42 inflammation-associated vascular occlusion 43 and cancer metastasis. 44 Moreover, DNase I (Pulmo-zyme®) has been utilized clinically as a bona fide first line of treatment for cystic fibrosis without notable side effects. 45 Disruption of NETs, however, could impede the capacity of neutrophils to prevent commensal dissemination or eliminate the invading pathogen during leaky guts or GI infection, respectively. Herein, we observed that DNase I treatment indeed aggravated the pathogen burden in the colon, ceca and spleen, and worsened colonic inflammation and hyperplasia. This suggests that the mucoprotective feature of PAD4 could be primarily mediated through formation of NETs, though further studies should consider whether other non-NETs-related role of PAD4 may also be involved in conferring protection against CR. However, administration of the PAD4 inhibitor, Cl-amidine, resulted in only a partial exacerbation of CR infection. Such outcomes suggest that CR infection could be aggravated by loss of NETs, but its severity may differ depending on the mode of NETs inhibition via genetic deficiency or pharmacological intervention. It is tempting to speculate that a higher dose of Cl-amidine may be required in order to recapitulate the severe disease observed in CR-infected Pad4 −/− mice and DNase I-treated mice. Nevertheless, the Taken together, our findings were in contrast with other reports demonstrating the beneficial effects of PAD4 inhibition in alleviating the severity of inflammatory arthritis, 46 promoting survival during sepsis 47, 48 and ameliorating SLE, 49 atherosclerosis 50 and dextran sodium sulfate-induce colitis in mice. 51 Such disparity suggests that the effects of PAD4 may be contextdependent and varied according to underlying causative agent(s) of the disease. It is possible that NETs formed against CR infection may have adverse effects to some extent, but such effects are outweighed by its protective role in limiting pathogen burden and dissemination. Further studies are certainly warranted to determine whether inhibiting PAD4 could have detrimental effects against other systemic or localized infection(s) mediated by various pathogens. It would be important for future studies to also consider the contribution of other non-canonical NETs formation, e.g., PAD4-independent NETosis and mitochondrial NETosis, 52 against bacterial infection. Collectively, our study underscores the critical role of PAD4 at the mucosal surfaces during enteropathogen infection. (Minneapolis, MN). SYBR Green mix and the qScript complementary DNA (cDNA) synthesis kit were procured from Quanta BioSciences (Gaithersburg, MD). Ly6G antibody was purchased from Abcam (Cambridge, MA). All other fine chemicals used in the present study were reagent grade and procured from Sigma. Alcian Blue (pH 2.5) Stain Kit was obtained from Vector Laboratories (Burlingame, CA). Mouse Lamina Propria Dissociation Kit was purchased from Miltenyi Biotec (Auburn, CA). Cl-amidine (hydrochloride) was obtained from Cayman chemicals (Ann Arbor, MI).
METHODS
Reagents
Mice
Pad4 −/− mice on C57BL/6 background was generated by Dr. Yanming Wang (Pennsylvania State University, University Park, PA) and bred with BL/6 wild type (WT) mice in our colony. The resulting offspring were crossed to generate homozygous Pad4 −/− mice and their WT littermates. These mice were bred in-house in the animal facility at University of Toledo and Pennsylvania State University under SPF conditions. All of the mice are on the C57BL/ 6 (BL6) background and were crossed with BL6 WT mice for > 10 generations. This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health and was approved by the Institutional Animal Care and Use Committee (IACUC) at The Pennsylvania State University and University of Toledo.
C. rodentium infection C. rodentium strain ICC169 (nalidixic acid-resistant) and bioluminescent strain ICC180 (kanamycin-resistant) were kind gifts from Dr. Gad Frankel (London School of Medicine and Dentistry, London, United Kingdom) via Dr. Margherita T. Cantorna (Pennsylvania State University, University Park, PA). The ICC169 strain was cultured in Luria-Bertani (LB, Sigma) broth containing 50 µg/ml nalidixic acid (Sigma), whereas the ICC180 strain was cultured in LB broth containing 100 µg/ml kanamycin (Sigma). Pad4 −/− mice and their WT littermates (male, 8 weeks) were infected by oral gavage with 1 × 10 9 colony forming unit (CFU) in 100 µl of PBS. Mice were monitored for body weight and euthanized at 10 and 28 days of p.i. To monitor CR fecal shedding and dissemination, feces and other tissues were collected, homogenized and plated in serial dilutions on LB agar plates containing nalidixic acid. Plates were incubated overnight at 37°C for CFU counting.
For in vivo infection kinetics study, 1 × 10 10 CFU of C. rodentium ICC180 was used. WT and Pad4 −/− mice were fed with alfalfa-free purified diet (Research Diets Inc., New Brunswick, NJ) to minimize the background luminescence from chlorophyll present in grainbased chow. Following infection, the animals were imaged every other day using the IVIS spectrum animal imaging system (Xenogen Corp., Alameda, CA, USA). Images were analyzed by Living Image software (PerkinElmer, Waltham, MA). Feces and other tissues were Fig. 4 Pad4 −/− mice were more susceptible to C. rodentium infection than WT mice. WT and Pad4 −/− mice (male, 8 weeks, n = 3) were intragastrically challenged with bioluminescent C. rodentium (1 × 10 10 CFU). a Whole-body imaging of WT and Pad4 −/− mice infected with bioluminescent C. rodentium (CR) that were taken every other day using the IVIS spectrum animal imaging system. The image shows one mouse from a total of three mice per treatment group. b Mice were euthanized at day 14 post-infection and analyzed for whole intestine using IVIS spectrum animal imaging system collected, homogenized and plated in serial dilutions on LB agar plates containing kanamycin and CFU were quantified.
DNase I treatment
Pad4 −/− mice and their WT littermates (male, 8 weeks) were administered 50 µg i.p. DNase I (dornase alfa, Genentech) 3 h after CR infection and once daily for the next 3 consecutive days and then once every alternate day until day 11. Control mice were given 100 µl of vehicle control (8.77 mg/ml NaCl and 0.15 mg/ml CaCl 2 ). 7 Inhibiting PAD4 via Cl-amidine treatment Pad4 −/− mice and their WT littermates (male, 8 weeks) were administered Cl-amidine (20 mg/kg b.wt/mice) i.p. 3 h prior to CR infection, followed by daily injections for the next 3 consecutive days and then once every alternate day until day 11. Control mice were given 100 µl of vehicle control (PBS, ×1).
Euthanasia and blood collection
At termination of the experiment, mice were euthanized via CO 2 asphyxiation and analyzed for standard colitis parameters. Blood was collected at the time of euthanasia in BD microtainers (Becton, Dickinson) via cardiac puncture. Hemolysis-free serum was obtained after centrifugation and stored at −80°C until further analysis.
Quantifying C. rodentium CFU Fecal samples from CR-infected mice were collected, weighed and then homogenized in sterile phosphate-buffered saline (PBS, 100 mg/ml). Cecal content, mesenteric lymph nodes (MLNs) Fig. 5 DNase I treatment enhanced C. rodentium infection in WT mice. WT mice (male, 8 weeks, n = 6) were infected with 1 × 10 9 CFU of C. rodentium (CR) by oral gavage. One group of mice were treated with DNase I (dornase alfa, 50 µg/mice, i.p.) at 3 h of post infection (p.i.), followed by once daily for the next 3 consecutive days and then once every alternative days. Mice were monitored for (a) body weight and (b) fecal shedding of CR (CFU) at different time points. Mice were euthanized at day 11 p.i. and CR burden was measured in (c) fecal samples, (d) cecal content and (e) spleen. f Fecal Lcn2, (g) serum Lcn2 and (h) SAA were determined by ELISA. i Colons (proximal to distal portion) were used for H&E staining, and Alcian blue staining for goblet cells. j Colonic histology was scored by visualizing the entire H&E-stained colon sections microscopically for the extent of epithelial hyperplasia, immune cells infiltration (ICI) in mucosa and submucosa, goblet cell loss, distortion of crypt structure, ulceration and crypt loss. Results are expressed as means ± SEM. *p < 0.05; **p < 0.01 and spleen were aseptically collected and homogenized in PBS (100 mg/ml). The homogenates were centrifuged at 200 rpm for 1 min, serially diluted and plated (100 µl) on LB agar plates containing either nalidixic acid or kanamycin. Plates were incubated overnight at 37°C and the CFU was counted.
Quantitative reverse-transcriptase polymerase chain reaction Distal colons were collected in RNAlater (Sigma) and stored in −80°C. Total mRNA was extracted by using Trizol reagent (Sigma) as described in the manufacturer's protocol. mRNA (0.5 µg) was used to synthesize cDNA for qRT-PCR using SYBR green (Quanta) according to manufacturer's protocol. The sequences of primers used for quantitative reverse-transcriptase polymerase chain reaction were (sense and antisense, respectively): KC 5′-TTGTGCGAAAAGAAGTGCAG-3′, and 5′-TACAAACACA GCCTCCCACA-3′; tumor necrosis factor alpha (TNF-α) 5′-ACTCC AGGCGGTGCCTATGT-3′ and 5′-AGTGTGAGGGTCTGGGCCAT-3′; iNOS 5′-TTTGCTTCCATGCTAATGCGAAAG-3′, and 5′-GCTCTGTTGA GGTCTAAAGGCTCCG-3′; 53 IL-6 5′-ACAACGATGATGCACTT-3′ and 5′-CTTGGTCCTTAGCCACT-3′; IL-17 5′-TCATCCCTCAAAGCTCAGC G-3′ and 5′-TTTCCCTCCGCATTGACAGA-3′; IFN-γ 5′-TCAAGTGGC ATAGATGTGG-3′ and 5′-TGGCTCTGCAGGATTTTCAT-3′; IL-1β 5′-T TGACGGACCCCAAAAGAT-3′ and 5′-AGAAGGTGCTCATGTCCTG-3′ and 36B4 5′-TCCAGGCTTTGGGCATCA-3′ and 5′-CTT TATTCAGCT GCACATCACTCAGA-3′. 19 36B4 was used to normalize relative mRNA expression using Ct (2 ΔΔCt ) method. Fold change was determined by comparison to the untreated control group.
Enzyme-linked immunosorbent assay (ELISA) Reconstitution of fecal samples was performed as described previously. 19 Briefly, frozen or freshly collected feces were reconstituted in PBS containing 0.1% Tween 20 to make 100 mg/ml fecal suspension and vortexed for 30 min at room temperature. Fecal suspensions were centrifuged at 4°C for 10,000×g for 10 min and the clear supernatants were collected. Samples from CR-infected mice were titrated for optimal dilution, whereas samples from controls were diluted 1:10 to be analyzed for fecal lipocalin 2 (Lcn2) using Duoset ELISA kits according to manufacturer instructions. Fecal IgA was measured via ELISA using standard procedures as described previously. 54 Polygonal goat anti-mouse IgA and HRP-conjugated goat anti-mouse IgA (Southern Biotechnology) were used as capture and detection antibody, respectively. A standard curve was generated using mouse IgA (κ isotype) control mAb (BD Biosciences).
Hemolysis-free sera were collected from CR-infected WT and Pad4 −/− mice. Lcn2, serum amyloid A (SAA), keratinocyte-derived chemoattractant (KC, alias CXCL1), neutrophil elastase (NE) and myeloperoxidase (MPO) were measured in serum via Duoset ELISA kits from R&D Systems. Colonic samples were homogenized in RIPA buffer (100 mg/ml, Cell Signaling) containing 1x protease inhibitor cocktail (Roche) and were centrifuged at 4°C at 12,000×g for 10 min. The clear supernatants were collected, diluted and analysed using IL-22 and IL-17A Duoset ELISA kits according to the manufacturer instructions.
Serum immunoreactivity to bacterial proteins E. coli (K12 strain) was grown overnight in Luria Bertani (LB) medium, pelleted by centrifugation and lysed in RIPA buffer (Cell Signaling) with protease inhibitor cocktail (×1, Roche). Lysates (40 µg protein per lane) were fractionated via SDS-PAGE. Proteins were transferred to PVDF membrane and probed with sera (1:1000) from control either CR-infected WT or Pad4 −/− mice for overnight at 4°C, followed by 1 h incubation with anti-mouse HRP (1:000). Immunoblot was developed by LI-COR Odyssey CLX method.
Lamina propria immune cells isolation
Colonic tissues from controls and CR-infected WT and Pad4 −/− mice were dissociated to single-cell suspensions by combining Fig. 6 Cl-amidine treatment modestly enhanced the susceptibility of C. rodentium infection in WT mice. WT mice (male, 8 weeks, n = 6) were infected with 1 × 10 9 CFU of C. rodentium (CR) by oral gavage. One group of mice were treated with Cl-amidine (20 mg/kg b.wt/mice, i.p.) at 3 h prior to infection, followed by once daily for the next 3 consecutive days and then once every alternate days. Mice were monitored for (a) body weight and (b) fecal shedding of CR determined by CFU at day 11 p.i.. c Fecal Lcn2 and (d) serum Lcn2 were determined by ELISA. e Colons (proximal to distal portion) were used for H&E staining. f Colonic histology was scored by degree of epithelial hyperplasia, immune cells infiltration (ICI) in mucosa and submucosa, goblet cell loss, distortion of crypt structure, ulceration and crypt loss. Results are expressed as means ± SEM. *p < 0.05; **p < 0.01 mechanical dissociation and enzymatic degradation, followed by lamina propria immune cells isolation according to manufacturer's instructions (mouse Lamina Propria Dissociation Kit, Miltenyi Biotec).
Flow cytometric characterization of lamina propria immune cells
Lamina propria immune cells (2.0 × 10 5 /200 µl) were stained with fluorophore-conjugated anti-mouse monoclonal antibodies (BD Bioscience), directed against the following cell surface proteins: CD3-PE and CD4-PE-Cy7, in staining buffer (BD Bioscience) and incubated for 30 min at room temperature in the dark. After surface staining, cells were washed in PBS, fixed and permeabilized with FoxP3 Staining Buffer Kit (BD Bioscience) according to manufacturer's instructions and incubated with FoxP3-Alexa Fluor 488 and RORγt-Alexa Fluor 647 for 1 h at room temperature. Cells were washed twice in FACS Buffer and were analyzed by Accuri c6 flow cytometer (BD Biosciences) with BD Accuri C6 Software (Becton Dickinson). Immune cells were defined by using surface markers: regulatory T cells (Treg) CD3 + CD4 + FoxP3 + ; Th17 cells CD3 + CD4 + RORγt + .
Histology and Immunohistochemistry
Colons from control and CR-infected mice were washed with PBS to get rid of fecal contents and opened longitudinally along the mesenteric border and Swiss-rolled from the proximal to distal end. The Swiss-rolls were placed in 10% neutralbuffered formalin for 24 h and transferred to 70% ethanol, and processed to generate 5 µm sections for histochemical and immunohistochemical staining. Hematoxylin & eosin staining were performed to observe the morphological and histopathological changes like crypt structure, ulceration and crypt loss, epithelial hyperplasia, mucosal thickening, and extent of immune cell infiltration (ICI) in mucosa and submucosa. To stain acidic mucin in the goblet cells, Alcian blue staining (pH 2.5) was performed using a Kit from Vector Laboratories (Burlingame, CA).
To detect NETs, colon sections were deparaffinized, antigenretrieved, permeabilized and then blocked with 10% donkey serum. Subsequently, the sections were incubated with rat antineutrophil Ly6G (1:500, Abcam) and rabbit anti-citrullinated histone 3 (citrulline R2 + R8 + R17) antibody (1:200, Abcam) overnight at 4°C. After washing with PBS, the sections were incubated with donkey anti-rat Alexa Fluor 594 and donkey anti-rabbit Alexa Fluor 488 conjugated antibody (Invitrogen/ ThermoFisher Scientific) for 1 h at RT. Sections were mounted with Fluoroshield™ DAPI (Sigma) and imaged via using VS120 Virtual Slide Microscope (Olympus) and the OlyVIA software.
The apoptotic cells were detected via TUNEL labeling as per manufacturers protocol (In Situ Cell Death Detection Kit, Roche/ Millipore Sigma). The TUNEL-stained sections were mounted with Fluoroshield™ DAPI (Sigma) and imaged via using VS120 Virtual Slide Microscope (Olympus) and the OlyVIA software.
Statistics
All data were represented as mean ± SEM. The statistical significance between two groups was calculated using unpaired, two-tailed t-test. Data from more than two groups was compared using a one-way ANOVA followed by Tukey's multiple comparison tests (when to compare the mean of each column with the mean of every other column). The p values < 0.05 were considered statistically significant and are denoted as *p < 0.05; **p < 0.01 and ***p < 0.001. All statisticalanalyses were performed with GraphPad Prism 7.0 software (GraphPad, La Jolla, CA).
